Title |
Barriers to effective treatment of vaginal atrophy with local estrogen therapy
|
---|---|
Published in |
International Journal of General Medicine, March 2013
|
DOI | 10.2147/ijgm.s43192 |
Pubmed ID | |
Authors |
Suzanne Reiter |
Abstract |
Vaginal atrophy is a common condition among postmenopausal women, among whom many exhibit both vulvovaginal symptoms (eg, dryness, irritation, itching, and pain with intercourse) and urinary symptoms (eg, increased frequency, urgency, incontinence, urinary tract infections, and dysuria). Unfortunately, few women with symptoms of vaginal atrophy report seeking treatment from a health care provider. The goal of this article is to examine reasons why patients and health care providers do not engage in discourse regarding this important topic. It is important to initiate conversations with postmenopausal women and counsel them on both why the changes occur and potential treatment options. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 1 | 50% |
Practitioners (doctors, other healthcare professionals) | 1 | 50% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 3% |
Unknown | 34 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 9 | 26% |
Student > Ph. D. Student | 4 | 11% |
Student > Bachelor | 2 | 6% |
Student > Postgraduate | 2 | 6% |
Other | 2 | 6% |
Other | 4 | 11% |
Unknown | 12 | 34% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 13 | 37% |
Agricultural and Biological Sciences | 2 | 6% |
Computer Science | 2 | 6% |
Biochemistry, Genetics and Molecular Biology | 1 | 3% |
Business, Management and Accounting | 1 | 3% |
Other | 4 | 11% |
Unknown | 12 | 34% |